Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09SCP
|
|||
Former ID |
DIB011872
|
|||
Drug Name |
ADXS-PSA
|
|||
Synonyms |
Advaxis PSA; Lovaxin P; Lm CLLO CPSA; ADXS31-142; PSA/Listeria vector (cancer), Advaxis; Prostate specific antigen/Listeria vector (cancer), Advaxis
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 1/2 | [1], [2], [3] | |
Company |
Advaxis Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostate specific antigen (KLK3) | Target Info | Modulator | [4] |
KEGG Pathway | Pathways in cancer | |||
Prostate cancer | ||||
Pathway Interaction Database | Coregulation of Androgen receptor activity | |||
Regulation of Androgen receptor activity | ||||
FOXA1 transcription factor network | ||||
Reactome | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | ||||
WikiPathways | Prostate Cancer | |||
Androgen receptor signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 4 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2373). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.